These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 11854201

  • 1. Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
    Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Van den Braak N, Jacobs BC, Van Doorn PA.
    Infect Immun; 2002 Mar; 70(3):1202-8. PubMed ID: 11854201
    [Abstract] [Full Text] [Related]

  • 2. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N.
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW, De Klerk MA, Endtz HP, Jacobs BC, Laman JD, van der Meché FG, van Doorn PA.
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N.
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [Abstract] [Full Text] [Related]

  • 6. Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits.
    Ang CW, Noordzij PG, de Klerk MA, Endtz HP, van Doorn PA, Laman JD.
    Infect Immun; 2002 Sep; 70(9):5081-5. PubMed ID: 12183556
    [Abstract] [Full Text] [Related]

  • 7. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N.
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.
    Godschalk PC, Kuijf ML, Li J, St Michael F, Ang CW, Jacobs BC, Karwaski MF, Brochu D, Moterassed A, Endtz HP, van Belkum A, Gilbert M.
    Infect Immun; 2007 Mar; 75(3):1245-54. PubMed ID: 17261613
    [Abstract] [Full Text] [Related]

  • 12. Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome.
    Jacobs BC, Endtz HP, van der Meché FG, Hazenberg MP, de Klerk MA, van Doorn PA.
    J Neuroimmunol; 1997 Oct; 79(1):62-8. PubMed ID: 9357448
    [Abstract] [Full Text] [Related]

  • 13. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N.
    J Peripher Nerv Syst; 1998 Oct; 3(1):3-18. PubMed ID: 10959233
    [Abstract] [Full Text] [Related]

  • 14. Infectious origins of, and molecular mimicry in, Guillain-Barré and Fisher syndromes.
    Yuki N.
    Lancet Infect Dis; 2001 Aug; 1(1):29-37. PubMed ID: 11871407
    [Abstract] [Full Text] [Related]

  • 15. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
    Islam Z, Gilbert M, Mohammad QD, Klaij K, Li J, van Rijs W, Tio-Gillen AP, Talukder KA, Willison HJ, van Belkum A, Endtz HP, Jacobs BC.
    PLoS One; 2012 Aug; 7(8):e43976. PubMed ID: 22952833
    [Abstract] [Full Text] [Related]

  • 16. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
    Yuki N, Miyatake T.
    Ann N Y Acad Sci; 1998 Jun 19; 845():330-40. PubMed ID: 9668366
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.